A5057863280- Coronary Interventions and Diagnostics
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Infective Endocarditis Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Aortic Disease and Treatment Approaches
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Central Venous Catheters and Hemodialysis
- Cardiac Health and Mental Health
- Cardiac and Coronary Surgery Techniques
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
- Aortic aneurysm repair treatments
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Healthcare Systems and Practices
- Atrial Fibrillation Management and Outcomes
- Pulmonary Hypertension Research and Treatments
- Acute Kidney Injury Research
Heart Hospital Baylor Plano
2016-2020
San Diego Cardiac Center
2020
Abbott Northwestern Hospital
2018-2019
Minneapolis Heart Institute Foundation
2019
Baylor University
2017-2018
Baylor Scott & White Health
2017
The University of Texas Southwestern Medical Center
2007-2016
Cardiopulmonary Research Science and Technology Institute
2014-2016
Medical City Dallas Hospital
2012-2016
Hospital of the University of Pennsylvania
2012-2016
Recent reports suggest that off-label use of drug-eluting stents is associated with an increased incidence adverse events. Whether the bare-metal would yield different results unknown.
Numerous definitions have been proposed for the diagnosis of myocardial infarction (MI) after coronary revascularization. The universal definition MI designates post procedural biomarker thresholds defining percutaneous intervention (PCI)-related (type 4a) and artery bypass grafting (CABG)-related 5) which are uncertain prognostic importance. In addition, both types cTn is recommended as choice, significance less well validated than CK-MB. Widespread adoption a not clearly linked to...
Background— Women <50 years of age with coronary artery disease may represent a group at higher risk for recurrent ischemic events after percutaneous intervention (PCI); however, no long-term, multicenter outcomes assessment exists in this population. Methods and Results— Using the National Heart, Lung, Blood Institute Dynamic Registry, we evaluated association sex on cardiovascular-related in10 963 patients (3797 women, 394 years) undergoing PCI followed 5 years. Death, myocardial...
The GuideLiner catheter (Vascular Solutions, Minneapolis, MN) is a novel, rapid exchange that allows deep vessel intubation. We describe 21 patients in whom the [7 French (F) 76% and 6F 24%] was used to facilitate equipment delivery (n = 14) or engagement 7). Pressure dampening after insertion observed 12 (57%). procedure successfully completed 19 (90%) one patient developed acute closure, likely due dissection. can complex coronary interventions but should be with caution minimize risk for injury.
Background: We examined the procedural outcomes of chronic total occlusions (CTO) percutaneous coronary interventions in patients with prior artery bypass graft surgery (CABG). Methods and Results: compared clinical, angiographic characteristics 3486 CTO performed (n=1101) without (n=2317) CABG at 21 centers. Prior (32% cohort) were older (67±9 versus 63±10 years; P <0.001) had more comorbidities lower left ventricular ejection fraction (50% [40–58] 55% [45–60]; <0.001). The target...
To compare iliofemoral arterial complications with transfemoral transcatheter aortic valve replacement (TF-TAVR) utilizing surgical cutdown versus percutaneous access closure devices in a randomized trial.Major vascular following TAVR are significant risk of the procedure. There no data comparing whether method TF-TAVR influences such complications.From June to December 2011, 30 consecutive patients undergoing were either (C) or (P) access. Subjects underwent preoperative CT scans, pre- and...
Objectives To examine whether transcatheter aortic valve replacement (TAVR) is a safe and effective treatment option for stenosis in patients with end‐stage renal disease (ESRD). Background Patients ESRD undergoing surgical have an operative mortality approaching 20% 10‐year survival of approximately 12%. We investigated TAVR more reasonable option. Methods This multicenter, retrospective study all who underwent 8 institutions between 12/2011 02/2013. Demographic characteristics, mortality,...